CARDIOTOXICITY
Clinical trials for CARDIOTOXICITY explained in plain language.
Never miss a new study
Get alerted when new CARDIOTOXICITY trials appear
Sign up with your email to follow new studies for CARDIOTOXICITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can exercise rebuild hearts damaged by cancer treatment?
Disease control Recruiting nowThis study is testing whether exercise can help protect the hearts of older breast cancer survivors. Many survivors face increased risk of heart problems after chemotherapy. Researchers will compare a 12-week exercise program to a gentle stretching program in 60 survivors over ag…
Matched conditions: CARDIOTOXICITY
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
Can a heart pill shield cancer patients from Treatment's hidden danger?
Disease control Recruiting nowThis study aims to protect the hearts of people with advanced HER2-positive breast cancer who are receiving a specific treatment (trastuzumab) that can sometimes damage the heart. It is observing nearly 500 patients to see how common heart problems are and testing if a common hea…
Matched conditions: CARDIOTOXICITY
Phase: PHASE3 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
Can exercise save young cancer Survivors' hearts?
Disease control Recruiting nowThis study is testing a special 6-month heart health program for young cancer survivors who are at risk for heart problems due to their past cancer treatments. The program combines supervised and home-based exercise with lifestyle coaching and is compared against standard advice.…
Matched conditions: CARDIOTOXICITY
Phase: NA • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC
-
Could tighter blood pressure control protect cancer Patients' hearts?
Disease control Recruiting nowThis study is testing whether keeping blood pressure extra low during breast cancer chemotherapy is safer and more effective at preventing heart damage than standard blood pressure care. Researchers will compare two different blood pressure targets in 130 women receiving chemothe…
Matched conditions: CARDIOTOXICITY
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Mar 11, 2026 14:54 UTC
-
Cancer survivors ask: can we stop the heart pills?
Disease control Recruiting nowThis study aims to find out if cancer survivors can safely stop taking heart failure medications after their heart function has returned to normal following cancer treatment side effects. Researchers will compare two groups: one that continues medications and one that stops them,…
Matched conditions: CARDIOTOXICITY
Phase: PHASE4 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Mar 09, 2026 14:23 UTC
-
New scans aim to catch Chemo's hidden heart damage in kids sooner
Diagnosis Recruiting nowThis study is testing whether newer, more sensitive heart scans can detect heart damage caused by chemotherapy and other cancer treatments earlier in children, teens, and young adult cancer survivors. It will follow 400 young people who have had cancer treatment to see if these s…
Matched conditions: CARDIOTOXICITY
Phase: NA • Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna • Aim: Diagnosis
Last updated Apr 01, 2026 14:42 UTC
-
Heart-Saving pill for chemo patients? major trial underway
Prevention Recruiting nowThis study is testing if a drug called empagliflozin can protect the heart from damage caused by powerful chemotherapy drugs (anthracyclines). It involves 220 cancer patients with healthy hearts who are scheduled for high-dose chemotherapy. Half will receive empagliflozin and hal…
Matched conditions: CARDIOTOXICITY
Phase: PHASE3 • Sponsor: Maria Sklodowska-Curie National Research Institute of Oncology • Aim: Prevention
Last updated Mar 30, 2026 14:29 UTC
-
AI steps in to guard cancer Patients' hearts
Knowledge-focused Recruiting nowThis study aims to create a better tool to predict which cancer patients might develop heart problems from certain powerful chemotherapy drugs. Researchers will use a computer program (machine learning) to analyze data from 600 patients receiving treatment. The goal is to identif…
Matched conditions: CARDIOTOXICITY
Sponsor: University Hospital, Caen • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC